University of Sousse   Report issue

Academic/Hospital Phase 1 Phase 4
Founded: Sousse Tunisia (2004)

Organization Overview

First Clinical Trial
2016
NCT03017248
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Faculty of medecine Sousse | Faculty of medicine of Sousse | Faculty of Medicine, Sousse | Université de Sousse

Active Ingredients

Drugs in Phase 4 Trials (2)

gabapentin (neurontin) (1 trial)

pregabalin (lyrica) (1 trial)

Drugs in Phase 1 Trials (2)

ketamine (ketalar) (1 trial)

morphine (1 trial)

Drugs in Other Trials (1)

tea (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Emergencies (Phase 1)

Pain, Postoperative (Phase 4)

Shoulder Pain (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 4
  • # of Trial APIs: 5